17-48908583-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_023079.5(UBE2Z):āc.80T>Gā(p.Val27Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000021 in 1,239,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023079.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2Z | NM_023079.5 | c.80T>G | p.Val27Gly | missense_variant | 1/7 | ENST00000360943.10 | NP_075567.2 | |
LOC105371814 | NR_135674.1 | n.45+356A>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2Z | ENST00000360943.10 | c.80T>G | p.Val27Gly | missense_variant | 1/7 | 1 | NM_023079.5 | ENSP00000354201.5 | ||
UBE2Z | ENST00000508468.2 | c.80T>G | p.Val27Gly | missense_variant | 1/3 | 3 | ENSP00000424543.1 | |||
SUMO2P17 | ENST00000508743.1 | n.45+356A>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 150946Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.0000184 AC: 20AN: 1088466Hom.: 0 Cov.: 31 AF XY: 0.0000214 AC XY: 11AN XY: 515074
GnomAD4 genome AF: 0.0000397 AC: 6AN: 150946Hom.: 0 Cov.: 30 AF XY: 0.0000543 AC XY: 4AN XY: 73664
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | The c.80T>G (p.V27G) alteration is located in exon 1 (coding exon 1) of the UBE2Z gene. This alteration results from a T to G substitution at nucleotide position 80, causing the valine (V) at amino acid position 27 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at